Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

100.0%

4 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01948219Not ApplicableTerminated

ENTegral Artificial Larynx Clinical Trial

Role: lead

NCT03325725Not ApplicableWithdrawn

Intra-laryngeal Implant for Treatment of Chronic Aspirations

Role: lead

NCT02437513Terminated

NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic Aspiration

Role: lead

NCT01587664Not ApplicableTerminated

NewBreez Safety and Efficacy Evaluation

Role: lead

All 4 trials loaded